Fonte: Dalton Transactions. Unidades: IQSC, IFSC
Assuntos: NEOPLASIAS, RUTÊNIO
ABNT
SILVA, Monize M. et al. Non-mutagenic Ru(II) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding. Dalton Transactions, v. 48, n. 39, p. 14885-14897, 2019Tradução . . Disponível em: https://doi.org/10.1039/C9DT01905G. Acesso em: 07 set. 2024.APA
Silva, M. M., Camargo, M. S. de, Correa, R. S., Castelli, S., De Grandis, R. A., Takarada, J. E., et al. (2019). Non-mutagenic Ru(II) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding. Dalton Transactions, 48( 39), 14885-14897. doi:10.1039/C9DT01905GNLM
Silva MM, Camargo MS de, Correa RS, Castelli S, De Grandis RA, Takarada JE, Varanda EA, Deflon VM, Castellano EE, Cominetti MR, Desideri A, Batista AA. Non-mutagenic Ru(II) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding [Internet]. Dalton Transactions. 2019 ; 48( 39): 14885-14897.[citado 2024 set. 07 ] Available from: https://doi.org/10.1039/C9DT01905GVancouver
Silva MM, Camargo MS de, Correa RS, Castelli S, De Grandis RA, Takarada JE, Varanda EA, Deflon VM, Castellano EE, Cominetti MR, Desideri A, Batista AA. Non-mutagenic Ru(II) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding [Internet]. Dalton Transactions. 2019 ; 48( 39): 14885-14897.[citado 2024 set. 07 ] Available from: https://doi.org/10.1039/C9DT01905G